about
Pharmacodynamics, pharmacokinetics, and safety of the oral reversible P2Y12 antagonist AZD6140 with aspirin in patients with atherosclerosis: a double-blind comparison to clopidogrel with aspirinTriple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis.Cost-effectiveness of ticagrelor in acute coronary syndromes.Does Early Post-operative Administration of Aspirin Influence the Risk of Bleeding After Coronary Artery Bypass Graft Surgery? A Prospective Observational StudyMarine Diterpenes: Molecular Modeling of Thrombin Inhibitors with Potential Biotechnological Application as an Antithrombotic.Curcumin, hemostasis, thrombosis, and coagulation.MRS2179: a novel inhibitor of platelet function.
P2860
Q28195019-142280D0-333C-4E7E-ADD1-C2BDD58927DFQ33390176-8F236978-E09B-43D0-A8D7-6D2193CF4A87Q38080910-EDD40096-D952-45E1-8953-84F71E1AAD81Q41764487-D18E1A9E-B75B-4C45-8E24-57AE8A7AEEDFQ42314217-865CC32B-4748-421B-B755-5FD1AB690D32Q48156313-3100439B-C90C-4F85-96FF-7E7F1D845BD3Q55431156-FB2C7D68-C884-4376-B5CB-E5020ECB6219
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Antiplatelet therapy in cardiovascular disease
@ast
Antiplatelet therapy in cardiovascular disease
@en
Antiplatelet therapy in cardiovascular disease
@nl
type
label
Antiplatelet therapy in cardiovascular disease
@ast
Antiplatelet therapy in cardiovascular disease
@en
Antiplatelet therapy in cardiovascular disease
@nl
prefLabel
Antiplatelet therapy in cardiovascular disease
@ast
Antiplatelet therapy in cardiovascular disease
@en
Antiplatelet therapy in cardiovascular disease
@nl
P2860
P356
P1476
Antiplatelet therapy in cardiovascular disease
@en
P2093
M W H Behan
R F Storey
P2860
P304
P356
10.1136/PGMJ.2003.007062
P407
P577
2004-03-01T00:00:00Z